"I have worked with many consulting companies during my 11 years in the industry, and this was by far the best experience I have had."
— Client, Genentech
"I was very impressed with the level of industry knowledge...It was a pleasure to work with the team."
— Client, Pfizer
"I was somewhat cynical about the use of outside consultants...but Campbell Alliance is one of the few consulting companies that...creates real, value-added deliverables that move the initiative forward."
— Client, Amgen
"Prior to working with Campbell Alliance, I was a devotee of (another firm). You can count me officially as a convert..."
— Client, Valeant
Business Development
- Market Opportunity Assessment for Oncology Assets
- Out-Licensing Document Development
- Licensing Strategy
- European Partner and Opportunity Screen
- Partnership Materials Development for Follow-On Biologics
- Follow-On Biologics Market Assessment
- Blood Factor Product Reviews
- Medical Device Market Assessment
- Co-Promotion Preparation
- Business Model Development
- Evaluation of a Potential Partner
- Deal Review
- Business Overview and Opportunity Presentation
- Market Assessment for Licensing Opportunity
- Acquisition Opportunity Review
- Product Opportunity Review
- Licensing and Acquisition Opportunity Identification
- Neuroscience Strategy
- Opportunity Review
- US Launch Playbook
- OTC Product European Launch Playbook
- Product Launch Support
- Development Structure Redesign
- Assessment and Prioritization of In-Licensing Candidates
- Cardiovascular Global Franchise Strategy
- Strategy Discussion Document Development
- Forecast Model Development
- Market Assessment
- Product Acquisition
- Compound Assessment and Out-Licensing Plan
- Opportunity Review of Oncology Compounds
- Identification and Assessment of Potential In-Licensing Opportunities
- Valuation of Potential Licensing Opportunities
- Evaluation of an In-Licensing Opportunity
- Assessment of a European In-Licensing Opportunity
- Identification of Potential Outlicensing Partners
- Preparation for Partnering Negotiations
- Development of a New Business Model for a Life Sciences Company
- Out-Licensing Strategy and Support
- Development of an Ex-US Out-Licensing Strategy
- Assessment of an In-Licensing Opportunity in Oncology
- Assessment of an In-Licensing Opportunity in Diabetes
- Assessment of an In-Licensing Opportunity in Oncology
- Out-Licensing Support for an Improved Formulation of an Existing Product
- Market Opportunity Assessment and Out-Licensing Support for a New Formulation of an Existing Product
- Market Assessment and Out-Licensing Support for an Extended Release Version of an Existing Product
- Business Model Development
- Advisory Board Preparation
- Evaluation of An Innovative Biologic for Possible In-Licensing
- Review of Terms for Possible Co-Promotion Opportunity
- Due Dilligence To Determine Commercial Opportunity
- Evaluation of Commercial Viability for Promising Compound
- Structuring of Deal Terms
- Assessment of Market Potential for Three Products
- Review of Sales and Marketing Strategies
- product In-Licensing Opportunity Assessment
- In-Licensing Opportunity Evaluation
- Evaluation of An In-Licensing Opportunity
- Built Framework For Assessing Product Development Opportunities
- Conducted A High-Level Market Forecast Covering Multiple Geographic Areas
- Market Opportunity Assessment for Partnering
- Canadian Marketplace Assessment
- In-licensing Target Identification
- Identification and Assessment of Potential Development/Commercialization Partners for a Pharmaceutical Product
- Development of US Market Entry Strategy
- CA helps a client understand the commercial issues involved with combination therapies.
- Engagement to review innovative drug delivery opportunity
- Engagement to help a leading pharma company decide whether or not to in-license a product requiring a patient assistance program.
- Opportunity Assessments Regarding a Portfolio of Four Products
- Operational Planning for the Launches of Two Products in Six European Countries
- Strategy for an Innovative Combination Product
- Preliminary Due Diligence for a Potential Product Acquisition
- Strategy to Help a European Pharmaceutical Company Enter the US Market
- Benchmarking Study Analyzing Key Strategic Methods for Entering the US Pharmaceutical Market
- Evaluation of an Acquisition Opportunity
- Outlicensing Strategy for a Promising Phase II Compound
- Assessment of the Managed Markets Environment for a Potential In-Licensing Candidate
- Identification of In-Licensing Opportunities in Men's Health
- Identification and Assessment of Potential International Outlicensing Partners for a Transdermal CNS Product
- Assessment of a Potential In-Licensing Opportunity for an Emerging Pharmaceutical Company
- Development of an In-Licensing Strategy
- Assessment of an In-Licensing Opportunity
- Assessment of the Likely Managed Markets Environment Facing a New Product Being Considered for In-Licensing
- Analysis of a Portfolio of Products and Recommendations for Improving ROI
- Market Assessment and Revenue Forecasting Model to Evaluate an In-Licensing Opportunity
- Evaluation of Licensing/Partnership Options Regarding a Potential Blockbuster
- Market Potential Assessment of a Diagnostic Product at a Leading Pharmaceutical Company
- Raynaud’s Disease Market Research for a Leading Pharmaceutical Company
- Assessment of the Commercialization Potential of an Orphan Drug for a Leading Pharmaceutical Company
- Assessment of a Pharmaceutical In-Licensing Opportunity
- Development of a Corporate Licensing Presentation
- Preliminary Due Diligence Supporting the Senior Management of a Midsize Pharmaceutical Client in its Merger and Acquisition Efforts
- Comprehensive Out-Licensing Strategy
- Strategic Process Improvement for the Business Development Function of a Pharmaceutical Company
- Comprehensive Assessment of a $600 Million Licensing Opportunity
- Assistance in Presenting a Healthcare IT Start-up to Potential Customers in the Pharmaceutical Industry
- Facilitation of Relatonships Between a Healthcare IT Client and Potential Customers in the Pharmaceutical Industry
- Facilitation of a Cross-Industry Collaboration
- Assistance in Out-Licensing Compounds
- Combined Business Development and Marketing Strategy
- Development of a Long-Term Plan to Ensure Competitiveness
- Business Analysis to Enable Client to Secure Additional Financial Support